ARCHIVES

Ohio State to study center expansion.

This article is from The Cancer Letter archive.

Vol. 29 No. 35 | September 26, 2003

Download PDF Visit The Full Archive

Related Articles

Drug Development: FDA Grants Breakthrough Therapy Designation To CTL019 in ALL

June 11, 2014

Report: Rising Treatment Costs Due to 340B Discounts

May 16, 2014

First CCOP 3 Returns In; Payline Not Yet Determined; Goes to NCAB On Jan. 30

January 26, 1990

New Treatment Modalities For Endometrial Cancer

March 26, 2004

FDA Staff Failed To Explain Approval Standards, Correct Misconceptions.

April 13, 2007

M.D. Anderson signs collaboration agreement with Institut Gustave Roussy.

February 13, 2004